SOSV

All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.

Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.

AnimalBiome helps to restore gut health to the millions of dogs and cats in the US living with chronic digestive disorders by offering microbiome-based supplements and non-invasive diagnostics.

In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. Phable is marching onward to impact a billion lives over the next 5 years.

Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable (handheld) CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in San Francisco, California, United States.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Every day we flush precious information on our bodies down the toilet. Bisu helps people capture these data and lead healthier, happier lives. Our product is a home health lab that provides personalized advice to help you look, feel and perform at your best, through easy, accurate urine and saliva tests. We are graduates of HAX, the world's leading hardware accelerator, and have won numerous awards including Johnson & Johnson Innovation, MedTech Innovator, the Edison Awards, UK Tech Rocketship Awards and the British Business Awards. At CES 2020 we won the IHS Markit Innovation Award and were named by CNET as one of the top health-tracking devices.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Microgenesis SA specializes in developing medical technologies and treatments focused on reproductive health. Based in San José de la Rinconada, Spain, the company offers non-invasive diagnostic tests to identify imbalances in vaginal and intestinal microbiota that may contribute to infertility. Additionally, it provides dual tests to analyze microbiota imbalances linked to immunological issues in the endometrium, as well as tools and guidance for addressing complex reproductive health cases. Established in 1992, Microgenesis has introduced a fertility test and treatment aimed at restoring fertility potential, particularly for women who have experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, the company’s diagnostic approach detects subclinical inflammation that can adversely affect ovarian function and implantation. Their treatment protocol is drug-free and all-natural, extending their services to both OB-GYNs and direct-to-consumer markets.

EIO Diagnostics Inc. is a Canadian company focused on developing innovative tools to diagnose and prevent udder infections in dairy animals. Founded in 2017 and based in Duncan, the company offers the FirstLook Mastitis detection system, which employs a multispectral sensor to analyze images of the udder as animals enter the milk parlor. This technology allows dairy farmers to identify early indicators of mastitis, enabling them to address potential infections before they escalate. EIO Diagnostics combines expertise in dairy farming, machine learning, and agriculture to enhance animal health and improve operational efficiency for dairy producers.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

BioROSA Technologies Inc. develops a blood test for autism spectrum disorders (ASD). The company offers diagnostic tools to allow clinicians to determine who is at risk for ASD and enables therapeutic developments through blood-based biomarkers and machine learning tools. BioROSA Technologies Inc. was incorporated in 2018 and is based in Belmont, Massachusetts.

AnimalBiome helps to restore gut health to the millions of dogs and cats in the US living with chronic digestive disorders by offering microbiome-based supplements and non-invasive diagnostics.

Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable (handheld) CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in San Francisco, California, United States.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

Dalton Bioanalytics specializes in developing advanced analytical technology aimed at transforming blood analysis into a more efficient and cost-effective process. By digitizing the biochemical composition of blood, the company provides a comprehensive array of actionable health insights, addressing the limitations of traditional laboratory testing. This technology enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules, through a single assay. Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine. Founded in 2019, the company is headquartered in Los Angeles, California.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. Phable is marching onward to impact a billion lives over the next 5 years.

Microgenesis SA specializes in developing medical technologies and treatments focused on reproductive health. Based in San José de la Rinconada, Spain, the company offers non-invasive diagnostic tests to identify imbalances in vaginal and intestinal microbiota that may contribute to infertility. Additionally, it provides dual tests to analyze microbiota imbalances linked to immunological issues in the endometrium, as well as tools and guidance for addressing complex reproductive health cases. Established in 1992, Microgenesis has introduced a fertility test and treatment aimed at restoring fertility potential, particularly for women who have experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, the company’s diagnostic approach detects subclinical inflammation that can adversely affect ovarian function and implantation. Their treatment protocol is drug-free and all-natural, extending their services to both OB-GYNs and direct-to-consumer markets.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.

Optimize.health is a provider of a digital healthcare platform that enables the deployment of Remote Patient Monitoring (RPM) programs. It uses easy-to-use equipment and software. The software is designed to facilitate provider compliance when billing to new Medicare CPT codes for RPM while providing a great user experience for both patients and providers. Its system is designed to be profitable for physicians starting in the first month. Chuks Onwuneme, Jeff LeBrun, and Otto Sipe established the company in Seattle, Washington in 2015.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Microgenesis SA specializes in developing medical technologies and treatments focused on reproductive health. Based in San José de la Rinconada, Spain, the company offers non-invasive diagnostic tests to identify imbalances in vaginal and intestinal microbiota that may contribute to infertility. Additionally, it provides dual tests to analyze microbiota imbalances linked to immunological issues in the endometrium, as well as tools and guidance for addressing complex reproductive health cases. Established in 1992, Microgenesis has introduced a fertility test and treatment aimed at restoring fertility potential, particularly for women who have experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, the company’s diagnostic approach detects subclinical inflammation that can adversely affect ovarian function and implantation. Their treatment protocol is drug-free and all-natural, extending their services to both OB-GYNs and direct-to-consumer markets.

Microgenesis SA specializes in developing medical technologies and treatments focused on reproductive health. Based in San José de la Rinconada, Spain, the company offers non-invasive diagnostic tests to identify imbalances in vaginal and intestinal microbiota that may contribute to infertility. Additionally, it provides dual tests to analyze microbiota imbalances linked to immunological issues in the endometrium, as well as tools and guidance for addressing complex reproductive health cases. Established in 1992, Microgenesis has introduced a fertility test and treatment aimed at restoring fertility potential, particularly for women who have experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, the company’s diagnostic approach detects subclinical inflammation that can adversely affect ovarian function and implantation. Their treatment protocol is drug-free and all-natural, extending their services to both OB-GYNs and direct-to-consumer markets.

GlowDx is a company based in Midleton, Ireland, that focuses on revolutionizing the diagnosis of tropical diseases through innovative molecular technology. Founded in 2015, the company specializes in point-of-care testing, which decentralizes molecular testing and facilitates local access to diagnostic services. By doing so, GlowDx aims to alleviate both the economic and health burdens faced by patients in affected regions. Through its development of DNA computing for diagnostics, GlowDx is committed to improving healthcare outcomes in areas where traditional testing methods may be limited or unavailable.

AnimalBiome helps to restore gut health to the millions of dogs and cats in the US living with chronic digestive disorders by offering microbiome-based supplements and non-invasive diagnostics.

Every day we flush precious information on our bodies down the toilet. Bisu helps people capture these data and lead healthier, happier lives. Our product is a home health lab that provides personalized advice to help you look, feel and perform at your best, through easy, accurate urine and saliva tests. We are graduates of HAX, the world's leading hardware accelerator, and have won numerous awards including Johnson & Johnson Innovation, MedTech Innovator, the Edison Awards, UK Tech Rocketship Awards and the British Business Awards. At CES 2020 we won the IHS Markit Innovation Award and were named by CNET as one of the top health-tracking devices.

BioROSA Technologies Inc. develops a blood test for autism spectrum disorders (ASD). The company offers diagnostic tools to allow clinicians to determine who is at risk for ASD and enables therapeutic developments through blood-based biomarkers and machine learning tools. BioROSA Technologies Inc. was incorporated in 2018 and is based in Belmont, Massachusetts.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Metabolomic Diagnostics is a deep-tech company focused on creating innovative biomarker-based diagnostic solutions for complex diseases, particularly in the field of prenatal care. The company utilizes a mass spectrometry-based platform that allows for the simultaneous analysis of multiple biomarkers, facilitating accurate disease diagnosis and risk prediction. Their primary objective is to develop diagnostic tools capable of determining a woman's risk of developing serious pregnancy complications, such as preeclampsia and gestational diabetes, early in her pregnancy. By leveraging a robust pipeline that integrates advanced biomarker multiplexing with proprietary informatics and statistical methods, Metabolomic Diagnostics aims to enhance clinical assays for application in healthcare settings. The company's innovative approach is designed in collaboration with prenatal care providers to ensure meaningful impact on pregnancy management, ultimately improving outcomes for both mothers and infants. Founded in 2011 and based in Little Island, Ireland, Metabolomic Diagnostics is committed to empowering women with accurate risk information, enabling personalized care tailored to individual needs.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Dalton Bioanalytics specializes in developing advanced analytical technology aimed at transforming blood analysis into a more efficient and cost-effective process. By digitizing the biochemical composition of blood, the company provides a comprehensive array of actionable health insights, addressing the limitations of traditional laboratory testing. This technology enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules, through a single assay. Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine. Founded in 2019, the company is headquartered in Los Angeles, California.

Among the many miseries cancer brings, the anguish of the waiting for a diagnosis is one of the worst. We kill the some of this misery by majorly reducing the time for diagnostic tests. Which also makes diagnostic labs more productive and profitable. OaCP, incorporated in 2017 has developed and patented proprietary reagents that act directly on DNA radically increasing the efficiency of genetic tests for cancer diagnosis and also potentially speeding up a variety of other DNA processes in industry. With our solution, the time for the test is reduced from 3 days to only 2 hours and the cost per test is reduced by 50%. We have signed distribution agreements in Italy and Japan and we are continuously working on our business expansion and product development. OaCP already received seed investment from SOSV and is part of RebelBio accelerator program!

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.

Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable (handheld) CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in San Francisco, California, United States.

Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.

Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.

ENTR operates a curated marketplace focused on health and wellness, connecting consumers with premium products from leading global brands. Founded by Chelsea Hawk in 2019, the company is based in New York and Charlotte. ENTR aims to help individuals discover nutrient-dense ingredients and holistic health products that can enhance their diets. In addition to offering a variety of health-focused items, the platform provides information about product contents, supporting customers in making informed dietary choices. By promoting a healthy and enjoyable lifestyle, ENTR seeks to empower users to maintain balance in their lives through the integration of wellness into their daily routines.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

GlowDx is a company based in Midleton, Ireland, that focuses on revolutionizing the diagnosis of tropical diseases through innovative molecular technology. Founded in 2015, the company specializes in point-of-care testing, which decentralizes molecular testing and facilitates local access to diagnostic services. By doing so, GlowDx aims to alleviate both the economic and health burdens faced by patients in affected regions. Through its development of DNA computing for diagnostics, GlowDx is committed to improving healthcare outcomes in areas where traditional testing methods may be limited or unavailable.

Seein Health is a pro-pregnancy product developer. The company's products include thermometers, menstrual test strips, and innovative physiological parameter monitoring equipment. Through new medical and hardware services, we provide users with pregnancy-promoting products and overseas test-tube baby frozen eggs. .

Dalton Bioanalytics specializes in developing advanced analytical technology aimed at transforming blood analysis into a more efficient and cost-effective process. By digitizing the biochemical composition of blood, the company provides a comprehensive array of actionable health insights, addressing the limitations of traditional laboratory testing. This technology enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules, through a single assay. Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine. Founded in 2019, the company is headquartered in Los Angeles, California.

In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. Phable is marching onward to impact a billion lives over the next 5 years.

BioROSA Technologies Inc. develops a blood test for autism spectrum disorders (ASD). The company offers diagnostic tools to allow clinicians to determine who is at risk for ASD and enables therapeutic developments through blood-based biomarkers and machine learning tools. BioROSA Technologies Inc. was incorporated in 2018 and is based in Belmont, Massachusetts.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

Medical device startup developing a diagnostic platform for blood pressure monitoring utilizing a novel parameter

Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable (handheld) CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in San Francisco, California, United States.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

Seein Health is a pro-pregnancy product developer. The company's products include thermometers, menstrual test strips, and innovative physiological parameter monitoring equipment. Through new medical and hardware services, we provide users with pregnancy-promoting products and overseas test-tube baby frozen eggs. .

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

Every day we flush precious information on our bodies down the toilet. Bisu helps people capture these data and lead healthier, happier lives. Our product is a home health lab that provides personalized advice to help you look, feel and perform at your best, through easy, accurate urine and saliva tests. We are graduates of HAX, the world's leading hardware accelerator, and have won numerous awards including Johnson & Johnson Innovation, MedTech Innovator, the Edison Awards, UK Tech Rocketship Awards and the British Business Awards. At CES 2020 we won the IHS Markit Innovation Award and were named by CNET as one of the top health-tracking devices.

Chronomics Ltd, established in 2017 and headquartered in Norwich, United Kingdom, specializes in testing kits and an artificial intelligence platform designed for DNA methylation analysis. The company focuses on monitoring users' health and wellbeing by utilizing epigenetic information derived from DNA. Its offerings include insights into biological age, smoke exposure, metabolic state, health risks, and hereditary intolerances, along with predictions related to eye color. Through its innovative approach, Chronomics aims to provide a comprehensive understanding of individual health profiles.

AWB Health, founded in 2012, is a prominent workplace wellness company that offers a comprehensive digital platform focused on nutrition, medical guidance, fitness, emotional well-being, and environmental health. The company aims to enhance employee awareness and foster healthy habits through personalized health assessments and goal-setting features. Users receive tailored health reports and plans based on their individual health risk evaluations. In addition to its online services, AWB Health organizes engaging offline events to promote wellness. Businesses benefit from aggregated group health reports generated through big data analytics, allowing them to implement targeted programs that improve employee engagement and performance. AWB Health's clientele includes notable Fortune 500 companies such as Disney, Roche, Adidas, and Siemens, reflecting its commitment to facilitating health improvement in diverse corporate environments.

TestSharing is a food tech platform that provides consumers with accessible and affordable professional lab testing for food safety. By utilizing a mobile application, users can scan the barcode of food items to receive detailed reports on the presence of pesticides and heavy metals. This innovative approach enables individuals to conduct a safety check on their food before consumption, enhancing informed decision-making about their dietary choices. The platform aims to empower consumers with critical information about the quality of the food they consume.

Saana is a Healthcare Technology company built for chronic illness patients to empower them to fight back. Based on their patients' conditions, smart technology, the latest science & expert recommendations, they deliver personalized meals & wellness solutions to improve their quality of life and strengthen their immunity.

Machine Medicine Limited develops a health monitoring system that uses computer vision and artificial intelligence in order to extract health metrics. The system tracks activities, walking patterns, detects falls and disease signs, and alert families when an intervention is needed. The company was founded in 2014 and is headquartered in London, United Kingdom.

AnimalBiome helps to restore gut health to the millions of dogs and cats in the US living with chronic digestive disorders by offering microbiome-based supplements and non-invasive diagnostics.

Seein Health is a pro-pregnancy product developer. The company's products include thermometers, menstrual test strips, and innovative physiological parameter monitoring equipment. Through new medical and hardware services, we provide users with pregnancy-promoting products and overseas test-tube baby frozen eggs. .

CLINICAI Inc. develops and markets a technology that offers health monitoring of activities inside the bathroom. The technology is equipped with sensor network and artificial intelligence to track people’s health for wellness and early detection of gastrointestinal cancers and diseases. The company develops toilet sensor devices to scan stool and urines at homes. CLINICAI Inc. was founded in 2016 and is based in San Francisco, California.

Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable (handheld) CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in San Francisco, California, United States.

Among the many miseries cancer brings, the anguish of the waiting for a diagnosis is one of the worst. We kill the some of this misery by majorly reducing the time for diagnostic tests. Which also makes diagnostic labs more productive and profitable. OaCP, incorporated in 2017 has developed and patented proprietary reagents that act directly on DNA radically increasing the efficiency of genetic tests for cancer diagnosis and also potentially speeding up a variety of other DNA processes in industry. With our solution, the time for the test is reduced from 3 days to only 2 hours and the cost per test is reduced by 50%. We have signed distribution agreements in Italy and Japan and we are continuously working on our business expansion and product development. OaCP already received seed investment from SOSV and is part of RebelBio accelerator program!

BioROSA Technologies Inc. develops a blood test for autism spectrum disorders (ASD). The company offers diagnostic tools to allow clinicians to determine who is at risk for ASD and enables therapeutic developments through blood-based biomarkers and machine learning tools. BioROSA Technologies Inc. was incorporated in 2018 and is based in Belmont, Massachusetts.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.

Medical device startup developing a diagnostic platform for blood pressure monitoring utilizing a novel parameter

Metabolomic Diagnostics is a deep-tech company focused on creating innovative biomarker-based diagnostic solutions for complex diseases, particularly in the field of prenatal care. The company utilizes a mass spectrometry-based platform that allows for the simultaneous analysis of multiple biomarkers, facilitating accurate disease diagnosis and risk prediction. Their primary objective is to develop diagnostic tools capable of determining a woman's risk of developing serious pregnancy complications, such as preeclampsia and gestational diabetes, early in her pregnancy. By leveraging a robust pipeline that integrates advanced biomarker multiplexing with proprietary informatics and statistical methods, Metabolomic Diagnostics aims to enhance clinical assays for application in healthcare settings. The company's innovative approach is designed in collaboration with prenatal care providers to ensure meaningful impact on pregnancy management, ultimately improving outcomes for both mothers and infants. Founded in 2011 and based in Little Island, Ireland, Metabolomic Diagnostics is committed to empowering women with accurate risk information, enabling personalized care tailored to individual needs.

AWB Health, founded in 2012, is a prominent workplace wellness company that offers a comprehensive digital platform focused on nutrition, medical guidance, fitness, emotional well-being, and environmental health. The company aims to enhance employee awareness and foster healthy habits through personalized health assessments and goal-setting features. Users receive tailored health reports and plans based on their individual health risk evaluations. In addition to its online services, AWB Health organizes engaging offline events to promote wellness. Businesses benefit from aggregated group health reports generated through big data analytics, allowing them to implement targeted programs that improve employee engagement and performance. AWB Health's clientele includes notable Fortune 500 companies such as Disney, Roche, Adidas, and Siemens, reflecting its commitment to facilitating health improvement in diverse corporate environments.

EIO Diagnostics Inc. is a Canadian company focused on developing innovative tools to diagnose and prevent udder infections in dairy animals. Founded in 2017 and based in Duncan, the company offers the FirstLook Mastitis detection system, which employs a multispectral sensor to analyze images of the udder as animals enter the milk parlor. This technology allows dairy farmers to identify early indicators of mastitis, enabling them to address potential infections before they escalate. EIO Diagnostics combines expertise in dairy farming, machine learning, and agriculture to enhance animal health and improve operational efficiency for dairy producers.

Daeki has developed the saliva-based diabetes detection test, which provides a simple, quick and non-invasive alternative for patients to detect diabetes or prediabetes conditions at home.

All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.

Chronomics Ltd, established in 2017 and headquartered in Norwich, United Kingdom, specializes in testing kits and an artificial intelligence platform designed for DNA methylation analysis. The company focuses on monitoring users' health and wellbeing by utilizing epigenetic information derived from DNA. Its offerings include insights into biological age, smoke exposure, metabolic state, health risks, and hereditary intolerances, along with predictions related to eye color. Through its innovative approach, Chronomics aims to provide a comprehensive understanding of individual health profiles.

Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.

EIO Diagnostics Inc. is a Canadian company focused on developing innovative tools to diagnose and prevent udder infections in dairy animals. Founded in 2017 and based in Duncan, the company offers the FirstLook Mastitis detection system, which employs a multispectral sensor to analyze images of the udder as animals enter the milk parlor. This technology allows dairy farmers to identify early indicators of mastitis, enabling them to address potential infections before they escalate. EIO Diagnostics combines expertise in dairy farming, machine learning, and agriculture to enhance animal health and improve operational efficiency for dairy producers.

Every day we flush precious information on our bodies down the toilet. Bisu helps people capture these data and lead healthier, happier lives. Our product is a home health lab that provides personalized advice to help you look, feel and perform at your best, through easy, accurate urine and saliva tests. We are graduates of HAX, the world's leading hardware accelerator, and have won numerous awards including Johnson & Johnson Innovation, MedTech Innovator, the Edison Awards, UK Tech Rocketship Awards and the British Business Awards. At CES 2020 we won the IHS Markit Innovation Award and were named by CNET as one of the top health-tracking devices.

Among the many miseries cancer brings, the anguish of the waiting for a diagnosis is one of the worst. We kill the some of this misery by majorly reducing the time for diagnostic tests. Which also makes diagnostic labs more productive and profitable. OaCP, incorporated in 2017 has developed and patented proprietary reagents that act directly on DNA radically increasing the efficiency of genetic tests for cancer diagnosis and also potentially speeding up a variety of other DNA processes in industry. With our solution, the time for the test is reduced from 3 days to only 2 hours and the cost per test is reduced by 50%. We have signed distribution agreements in Italy and Japan and we are continuously working on our business expansion and product development. OaCP already received seed investment from SOSV and is part of RebelBio accelerator program!

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

GlowDx is a company based in Midleton, Ireland, that focuses on revolutionizing the diagnosis of tropical diseases through innovative molecular technology. Founded in 2015, the company specializes in point-of-care testing, which decentralizes molecular testing and facilitates local access to diagnostic services. By doing so, GlowDx aims to alleviate both the economic and health burdens faced by patients in affected regions. Through its development of DNA computing for diagnostics, GlowDx is committed to improving healthcare outcomes in areas where traditional testing methods may be limited or unavailable.

Sex Positive provides at-home STI tests so you can test yourself.

MediStar Health offers Chinese cancer patients real-time, virtual consultations with top, US cancer specialists. They strive to make careful examination of patient condition more accessible, to avoid major challenges such as misdiagnosis and overtreatment in the Chinese healthcare system.

ZiO Health specializes in the development of innovative biosensor technology that quantitatively analyzes various parameters in bodily and environmental fluids. The company offers a range of portable testing devices tailored for use in homes, hospitals, and other settings, aimed at enhancing health outcomes through molecular testing. Operating under the brands ELAPTA and ELOSIA, ZiO Health provides solutions such as ELOSIA, a home urine test designed to assess wellness parameters and deliver personalized nutrition and wellness advice. The company's devices facilitate the detection and measurement of chemical and biological substances, empowering users to optimize their health and prevent illness through effective home diagnostics and tailored testing solutions.

AnimalBiome helps to restore gut health to the millions of dogs and cats in the US living with chronic digestive disorders by offering microbiome-based supplements and non-invasive diagnostics.

Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Metabolomic Diagnostics is a deep-tech company focused on creating innovative biomarker-based diagnostic solutions for complex diseases, particularly in the field of prenatal care. The company utilizes a mass spectrometry-based platform that allows for the simultaneous analysis of multiple biomarkers, facilitating accurate disease diagnosis and risk prediction. Their primary objective is to develop diagnostic tools capable of determining a woman's risk of developing serious pregnancy complications, such as preeclampsia and gestational diabetes, early in her pregnancy. By leveraging a robust pipeline that integrates advanced biomarker multiplexing with proprietary informatics and statistical methods, Metabolomic Diagnostics aims to enhance clinical assays for application in healthcare settings. The company's innovative approach is designed in collaboration with prenatal care providers to ensure meaningful impact on pregnancy management, ultimately improving outcomes for both mothers and infants. Founded in 2011 and based in Little Island, Ireland, Metabolomic Diagnostics is committed to empowering women with accurate risk information, enabling personalized care tailored to individual needs.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.

Zika Virus, Dengue Fever, and other global pandemics ravish countries as a result of a lack of rapidly deployable field based diagnostics. mFluidX has created a DNA diagnostic test the size of a stick of gum that can be deployed and provide results in thirty minutes. All with a self-powered disposable chip that costs 1000x less than current bulky benchtop based lab diagnostics.

Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platform utilizes novel technologies to create mobile, point-of-care, and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing, enabling people to put healthcare information directly into their hands to improve their quality of life.

Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platform utilizes novel technologies to create mobile, point-of-care, and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing, enabling people to put healthcare information directly into their hands to improve their quality of life.

MYi Diagnostics & Discovery, Inc. develops diagnostic assays for the longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. It develops multi-analyte assays with single-cell sensitivity to replace diagnostics for individual cancers, infectious diseases, metabolic conditions, and other rare or common disorders, as well as generate actionable individualized information to streamline clinical intervention strategies. The company was incorporated in 2015 and is based in San Diego, California.